ATLANPOLE - Biothérapies

Thinking up tomorrow's medicine



DigitalforLife: Digital enterprises, meet health challenges

On May 28th, at the Ecole des Mines de Nantes, the fourth Digital & Health day took place. It was organized by Images & Réseaux and Atlanpole Biotherapies competitive clusters. The objective of this cycle of theme days is to develop closer links between professionals involved in health and digital sectors.

AAA Signs Distribution Agreement for Lutathera in Japan with FUJIFILM RI Pharma, Co., LTD

Advanced Accelerator Applications

[Press Release] Advanced Accelerator Applications S.A., an international specialist in Molecular Nuclear Medicine (MNM) and member of Atlanpole Biotherapies, announce s that it has entered into a distribution agreement for Lutathera in Japan with FUJIFILM RI Pharma, Co., LTD (“FRI”), a leading in - country distributor of nuclear medicine and diagnostic imaging products. Lutathera is currently in a pivotal Phase III trial, both in the US and EU, with results expected in Q3.

Press Release BIOMATLANTE obtains CE approval to market its OSTEOTWIN™ Affix Sheath


[Press Release] BIOMATLANTE (Vigneux de Bretagne ), a medical devices company specialized in bone regeneration and member of Atlanpole Biotherapies, today announced the CE regulatory approval of OSTEOTWIN™ Affix Sheath 1 , combining a polymer with its MBCP™ core technology, to significantly enhance fixation strength and graft protection. This product is the result of a development partnership between BIOMATLANTE and AMPLITUDE (Valence ).

Your company on BioMap France 2016

Biomap 2016

The only rigorous mapping of French biotech, which is free and has been updated annually for 13 years, the Biotech finances BioMap allows international investors and industrialists to locate, at a glance, the lifeblood of French bioindustry. This document, translated into English, is very widely distributed in international economic and financial spheres.

A successful second edition of BioBusiness Week

BioBusiness Week 2015

From June 8 - 12, 14 PhD students in biotechnology and nanomedicine from 8 different nationalities participated in the second edition of the BioBusiness Week that took place at the Angers Technopole. They benefited from the experience of European professionals ready to share their know-how and willing to coach students on different issues such as market studies, intellectual property, fundraising…

Official launch of PEPS, the Pharmaco-Epidemiology for Health Products consortium

Rennes University Hospital officially launches the Pharmaco-Epidemiology for Health Products (PEPS) consortium, funded by the National Security Agency of Medicine and health products (ANSM).

Your news


14 - 18 sept. : Biopharm 2015

Biopharm 2015

Meet our companies there :

16 - 18 sept. : CMSB 2015 in Nantes

CMSB 2015

The CMSB 2015 conference will be held in Nantes from Sept. 16th to Sept. 18th. The conference brings together computer scientists, biologists, mathematicians, engineers and physicists interested in a system-level understanding of biological processes.

Our events

The Atlanpole Biotherapies competitive cluster combines the expertise of laboratories, companies and technical departments for a public-private offer of services, comprehensive, relevant and competitive, in the value chain of bio-medicine from target discovery to clinical evaluation


Our ambition is to become a reference center on an international scale for the development of diagnostic and therapeutic solutions in the field of biotherapies.
Atlanpole Biotherapies is a competitive cluster certified by the Ministry of Industry (July 2005). 

Atlanpole UK